Blood test based on four-marker protein panel combined with risk prediction model may improve assessment of risk for lung cancer
Compared with 2013 USPSTF criteria, more patients eligible for lung cancer screening with less racial disparity in access
Predictive models based on comparison of serum metabolomic patterns for patients at time of lung cancer diagnosis and matched controls
But majority of U.S. Black women diagnosed with lung cancer still would have been ineligible for screening under 2021 USPSTF guideline
Distribution of Lung-RADS results did not differ for lung cancer screenings with telemedicine versus in-person visit
Newly eligible population includes individuals aged 50 to 54 years, more women, more racial and ethnic-minority groups
Aggregate out-of-pocket costs $427,069.74 for those undergoing LCS and downstream procedure; OOP cost per episode was $62.46
National LCS rates were unchanged between 2019 and 2020; significant declines seen in five states and increases recorded in 19 states
Seven graded recommendations and nine ungraded consensus statements developed for lung cancer screening
Adults aged 50 to 80 years with 20 pack-year smoking history who currently smoke or quit within last 15 years should be screened with low-dose CT